---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-124102"
form_type: "8-K"
ticker: "PASG"
cik: "0001787297"
company_name: "Passage BIO, Inc."
filed_at: "2022-12-02T23:59:59+00:00"
generated_at: "2026-06-21T10:21:30.377124+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Passage Bio amends bylaws to adopt universal proxy rules and DGCL updates

## Summary
- Revised advance notice provisions: requires additional disclosures from stockholders and limits nominees to board seats up for election.
- Added compliance with SEC Rule 14a-19 universal proxy: stockholders must certify compliance and provide evidence 5 business days before meeting.
- Updated adjournment procedures and stockholder meeting conduct to conform to recent DGCL amendments.
- Requires soliciting stockholders to use a proxy card color other than white.
- Added emergency bylaw provision for quorum during disasters.

## SEC filing metadata
- accession: 0001104659-22-124102
- form_type: 8-K
- ticker: PASG
- cik: 0001787297
- company_name: Passage BIO, Inc.
- filed_at: 2022-12-02T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1787297/000110465922124102/0001104659-22-124102-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1787297/000110465922124102/tm2231891d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-124102
- JSON: https://secwatch.observer/filing/0001104659-22-124102.json
- Plain text: https://secwatch.observer/filing/0001104659-22-124102.txt

## Key facts
- Governance Changes
  Passage BIO, Inc.: Board amended and restated bylaws to conform to recent DGCL amendments and universal proxy rules, effective December 1, 2022 (effective 2022-12-01).
  - Change: bylaw amendment
  - Effective: 2022-12-01
  source text: On December 1, 2022, in connection with the effectiveness of new Securities and Exchange Commission rules regarding universal proxy cards, certain recent changes to the Delaware General Corporation Law (the “ DGCL ”), and a periodic review of the amended and restated bylaws of Passage Bio, Inc. (the “ Company ”), the Board of Directors (the “ Board ”) of the Company amended and restated the Company’s bylaws (the “ Amended and Restated Bylaws ”), which became immediately effective.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1787297/000110465922124102/0001104659-22-124102-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.